Walk into any pharmacy or search any health website in India, and you will find anti-ageing supplements built around a single headline ingredient, NMN, resveratrol, or collagen, with the entire promise resting on that one compound. The science, however, tells a different story.
Ageing is not caused by one mechanism. It is fueled by a cascade of interconnected biological processes: NAD+ depletion, oxidative stress, mitochondrial decline, chronic inflammation and cellular DNA damage that play out simultaneously and feed into one another.
Hitting only one of these pathways leaves the others untouched. This is why the most sophisticated, evidence-based anti-ageing formulations for women have ingredient synergy at their heart, where lots of ingredients work in cascades across overlapping pathways to create benefits that no single element can deliver on its own.
This article explains the science behind that approach and how MITOV by Surishi Pharmaceuticals is formulated around it.
The Biology of Ageing: Why One Ingredient Is Never Enough
To understand why multi-ingredient formulations outperform single-ingredient supplements, you first need to understand what is actually happening inside the body as it ages.
Ageing is not one thing; it’s the slow unravelling of many interleaved systems, each one accelerating the degeneration of all the others. Five of the main biological processes driving cellular ageing in women look something like this:
- NAD+ depletion
NAD+ is a coenzyme in all cells that is crucial for energy production, DNA repair and the activation of sirtuin proteins involved in cellular health and longevity. NAD+ levels drop by about 50 per cent between ages 40 and 60, one of the most studied drivers of cellular ageing.
- Oxidative stress
Free radicals are byproducts of energy metabolism in cells. When antioxidant capacity decreases with age, oxidative damage to proteins, lipids and DNA accumulates, speeding skin ageing, cardiovascular decline and cognitive decline.
- Mitochondrial dysfunction
In concert with decreasing NAD+ and accumulating oxidative damage, mitochondria become less efficient, making less energy and producing greater damaging byproducts. This is closely associated with fatigue, metabolic deterioration and advanced cellular ageing.
- Chronic low-grade inflammation (inflammageing)
A chronic low-level elevation of inflammatory markers that injure tissues, promote cell senescence and drive age-associated metabolic and cardiovascular disorders different from acute inflammation and not self-limiting;
- Sirtuin pathway decline
Sirtuins are longevity proteins that modulate DNA repair, stress response, and metabolic function, but their activity depends entirely on NAD+ availability. As NAD+ levels fall, sirtuin activity declines.
Each of these mechanisms feeds into the others. NAD+ depletion impairs mitochondrial function. Mitochondrial dysfunction increases oxidative stress. Oxidative stress drives inflammation.
Inflammation suppresses NAD+ synthesis. Treating a single one of those pathways while leaving the rest active is like patching a single crack in a dam while letting the rest of the structure rot away.
The Science of Ingredient Synergy
Synergy in nutritional science is the occurrence by which two or more compounds result in a combined effect that is greater than the sum of their individual effects. It is not theoretical; it appears in clinical and preclinical studies involving several different combinations of ingredients. In the context of anti-ageing supplementation, synergy matters for three different reasons:
- Pathway complementarity
Mechanisms of action of compounds are diverse. NMN restores NAD+ levels. Resveratrol activates sirtuins. Pterostilbene lowers oxidation and inflammatory distress. EGCG shields you from free radical injury. Each focuses on a different node in the ageing cascade; together, they capture the whole picture.
- Bioavailability enhancement:
Some compounds facilitate the absorption or efficacy of others. Trans-pterostilbene is much more orally bioavailable than resveratrol, and the combination leads to substantially elevated and long-lasting plasma levels of both compounds compared with either alone.
- Dose efficiency
When compounds work synergistically, lower doses of each can produce effects that would require much higher doses of a single ingredient to achieve, if those effects are achievable with a single ingredient at all.
This is why leading longevity researchers consistently advocate for multi-ingredient approaches and why the most carefully designed women’s anti-ageing products are built around ingredient combinations rather than headline molecules.
NMN: The Foundation of Cellular Energy and Repair
Beta-Nicotinamide Mononucleotide (NMN) is converted directly and rapidly to produce NAD+. These are the most investigated NAD+ precursors to date and have garnered considerable scientific interest over the last decade for their roles in cellular energy metabolism and longevity. Here is what NMN does at the cellular level:
• Restores NAD+ levels, which decline by up to 50 per cent between ages 40 and 60, directly addressing one of the most documented mechanisms of cellular ageing.
• Activates SIRT1 and other sirtuins, which regulate DNA repair, mitochondrial biogenesis, and inflammatory gene expression.
• Supports mitochondrial function, improving cellular energy output and reducing damaging mitochondrial byproducts.
• May support healthy insulin sensitivity and metabolic function, both of which decline with age alongside NAD+.
• Has a favourable safety profile in human clinical trials at doses from 250mg to 500mg per day.
At 425mg per capsule, MITOV by Surishi Pharmaceuticals delivers NMN at a dose that reflects the research-informed range used in clinical studies, making it one of the highest-dose NMN formulations available in India’s women’s supplement market.
Resveratrol and Pterostilbene: The Sirtuin Activators
If NMN is the fuel for the NAD+ engine, then resveratrol and pterostilbene are the switches that control how this energy is utilised. Both are stilbene polyphenol compounds and powerful antioxidants with anti-inflammatory effects, and both activate sirtuins. The inclusion in MITOV, with NMN, was a conscious formulation choice driven by synergy science:
• Trans-resveratrol (25mg)
The most extensively researched sirtuin-activating compound, resveratrol, directly activates SIRT1, the sirtuin most dependent on maintaining longevity, metabolic health and cellular stress resistance. It also reduces key inflammatory mediators, such as NF-kB and mitochondrial ROS, and promotes cardiovascular health by enhancing endothelial function.
• Trans-pterostilbene (25mg)
Chemically similar to resveratrol but with much higher oral bioavailability, stomach and bloodstream levels grow much higher at the same dose. It upregulates several sirtuin isoforms, exhibiting neuroprotective effects and possessing complementary anti-inflammatory and metabolic-modulating properties.
NMN elevates NAD+; resveratrol and pterostilbene activate sirtuins that use NAD+; and the resulting sirtuin activity drives downstream improvements in DNA repair, mitochondrial efficiency, and inflammatory regulation, each compound amplifying the others.
EGCG and the Additional Protective Layer
Epigallocatechin Gallate (EGCG) is the most biologically active catechin in green tea and one of the most extensively researched plant polyphenols in the longevity literature. The addition of this component in MITOV at 2.5mg offers an additional protective layer that operates independently of the NMN-sirtuin pathway:
• Powerful free radical scavenger, neutralising reactive oxygen species and limiting oxidative damage to cell membranes, proteins and DNA.
• Inhibits the enzyme COMT (catechol-O-methyltransferase) that destroys resveratrol, meaning it may prolong the time frame during which resveratrol is active in the bloodstream, increasing the effectiveness of the dose of resveratrol
• Promotes healthy metabolic function, via its contributions to glucose regulation and fat oxidation, which take on greater importance as NAD+ levels and mitochondrial efficiency gradually deteriorate with age
• Shown anti-inflammatory effects via at least two different mechanisms, including NF-kB inhibition, which might synergise with the other resveratrol anti-inflammatory pathways
• Preclinical data that EGCG might activate AMPK, an energy-sensing enzyme that stimulates intracellular recycling processes involved in autophagy, the body’s means of clearing damaged cellular components
The EGCG in MITOV shows formulation intelligence at 2.5mg; it’s not a spotlight dose, but it extends resveratrol action while delivering complementary antioxidant and metabolic support that adds up to overall effectiveness.
Simarouba and Rhabdosia Rubescens: Botanical Precision
MITOV also includes two lesser-known but scientifically significant botanical ingredients, Simarouba at 10mg and Rhabdosia rubescens at 5mg, that reflect Surishi’s commitment to blending contemporary longevity science with the depth of botanical research. These are not filler ingredients. Each of them has a purpose for inclusion in a woman’s anti-ageing formulation that is evidence-informed:
• Simarouba (10mg):
Obtained from the Simarouba glauca tree, quassinoid compounds from this plant have demonstrated anti-inflammatory, antioxidant, and anti-proliferative properties in preclinical studies augments overall protective anti-inflammatory profile of the formulation.
• Rhabdosia rubescens (5mg):
A traditional medicinal herb rich in bioactive diterpenoids, including oridonin, with well-defined anti-inflammatory and antioxidant properties. In preclinical studies, it has been shown to modulate NF-kB and other major inflammatory pathways in a manner complementary to resveratrol and pterostilbene.
These botanicals reflect Surishi’s broader formulation philosophy: combining the latest in NAD+ precursor science with the accumulated evidence base around plant-derived anti-inflammatory compounds for a more complete approach to cellular longevity.
Why MITOV by Surishi Pharmaceuticals Represents This Approach
MITOV is Surishi Pharmaceuticals’ flagship anti-ageing formulation for women, built on the principle that the most effective approach to cellular longevity combines multiple ingredients addressing the ageing cascade from multiple angles simultaneously. Here is what makes the MITOV formulation distinctive:
• High-dose NMN at 425mg:
Consistent with the clinical research range, not the underdosed quantities found in products that lead with NMN as a marketing claim but deliver it at biologically insufficient levels.
• Dual stilbene combination:
Trans-resveratrol and trans-pterostilbene at 25mg each provide sirtuin activation through two compounds with complementary bioavailability profiles, maximising pathway support throughout the day.
• EGCG for extended resveratrol activity:
An advanced formulation decision showing how these compounds work in tandem to the benefit of your physiology, not just a line-up of trendy antioxidants tacked on for sales appeal.
• Botanical anti-inflammatory support:
Simarouba and Rhabdosia rubescens modulate the inflammageing pathway via mechanisms that synergise with the polyphenol components.
• WHO and GMP manufactured:
Each capsule is made to the highest pharmaceutical manufacturing standards; purity, potency and consistency are guaranteed.
MITOV is not a supplement built around a headline ingredient and a compelling story. It is a formulation built around a scientific rationale, and the difference is significant for women who are investing in their long-term cellular health with serious intent.
Who Is MITOV Most Relevant For
MITOV is formulated for women who take a proactive, research-informed approach to their health and who understand that the most meaningful investments in longevity are made before symptoms become evident rather than in response to them. Here is the profile of women for whom MITOV’s multi-ingredient formulation is most relevant:
• Women aged 30 and above who are beginning to notice the early signs of cellular and energetic decline, such as persistent fatigue, reduced cognitive sharpness, slower recovery, and changes in skin resilience that precede more significant age-related changes
• Women approaching or in perimenopause who are experiencing the accelerated NAD+ decline and inflammatory changes that accompany the hormonal transition of midlife
• Women with a family history of age-related conditions who want to support their cellular health proactively rather than reactively
• Health-conscious women who have researched NMN, resveratrol, or longevity science and are looking for a formulation that reflects the science rather than simplifying it
• Women who have tried single-ingredient supplements and found the results disappointing and are ready to understand why a synergistic approach may produce what a single compound could not
As with all supplements, MITOV is not a substitute for a healthy lifestyle; it is a sophisticated complement to one. Talk to your health care provider before starting any new supplement plan, especially if you have underlying health conditions or are taking medications.
Conclusion
The most important insight in longevity science is not about any single molecule. It is about understanding that ageing is a systems-level phenomenon and that addressing it effectively requires a systems-level response.
NMN restores the cellular energy currency that powers everything. Resveratrol and pterostilbene activate the proteins that use that energy for repair and protection. EGCG extends their action and provides complementary antioxidant defence. Simarouba and Rhabdosia rubescens address the inflammatory undercurrent that accelerates cellular deterioration.
This is the science behind why multi-ingredient anti-ageing formulations outperform single-ingredient supplements, and this is the science that MITOV by Surishi Pharmaceuticals is built on. Inspired innovation for women means not settling for a simplified solution when the evidence points clearly to a more sophisticated one.
Frequently Asked Questions
- Why does MITOV contain so many ingredients? Is more always better?
Not for the sake of more, each ingredient in MITOV targets a specific, distinct mechanism of cellular ageing. The combination is designed for synergy, not quantity.
- Can I take NMN alone without resveratrol and still get anti-ageing benefits?
NMN alone will raise NAD+ levels, but without sirtuin activators like resveratrol and pterostilbene, the downstream longevity pathways that depend on NAD+ remain underactivated. The combination produces effects that NMN alone cannot.
- Is MITOV suitable for women in their 30s, or is it only for older women?
NAD+ levels decline beginning in the mid-30s and accelerate through the 40s and 50s. Women in their 30s who are proactive about cellular health are among the most appropriate users of MITOV.
- How long does it take to notice results from a multi-ingredient supplement like MITOV?
Most women report improvements in energy and cognitive clarity within four to eight weeks of consistent use. Cellular and structural benefits accumulate over longer periods of consistent supplementation.
(Message in Public Interest by Surishi Pharmaceuticals | Makers of MITOV)
